The PI3K pathway is one of the most frequently activated pathways in cancer. PI3K inhibitors are a promising new class of drugs that target this pathway.
HISTORY / ORIGIN
PI3K inhibitors have been developed to inhibit the overactivation of the PI3K/Akt/mTOR signaling axis. Several types of small-molecule inhibitors have been developed, including pan-PI3K inhibitors, isoform-specific inhibitors, and dual PI3K/mTOR inhibitors.
TYPES OF PI3K INHIBITORS
PI3K inhibitors can be categorized by their target:
Pan-PI3K Inhibitors – Target all four class I PI3K isoforms. Examples include copanlisib.
Isoform-Specific PI3K Inhibitors – Target specific isoforms like PI3Kα. Idelalisib is an example.
Dual PI3K/mTOR Inhibitors – Target both PI3K and mTOR pathways.
PI3Kα Inhibitors – A specific subtype targeting the alpha isoform.
mTOR Inhibitors – Including allosteric mTORC1 inhibitors (rapalogues).
MATERIALS / KEY FEATURES
PI3K inhibitors have several key features:
Targeted Action – Specifically inhibit the PI3K pathway.
Small Molecule – Orally available drugs.
Multiple Isoforms – Different inhibitors target different isoforms.
Combination Potential – Can be combined with other therapies.
Clinical Trials – Numerous ongoing trials.
BENEFITS / WHY CHOOSE PI3K INHIBITORS
✅ Targeted therapy – Specifically targets cancer cells with PI3K pathway activation.
✅ Multiple options – Different inhibitors for different cancer types.
✅ Combination potential – Can be combined with other treatments.
✅ Oral administration – Convenient for patients.
✅ Ongoing research – New inhibitors and combinations are being developed.
CARE TIPS / USAGE TIPS
Discuss with your oncologist – PI3K inhibitors are used for specific cancer types.
Understand side effects – Like all targeted therapies, PI3K inhibitors have side effects.
Follow dosing instructions – Adhere to the prescribed dosing schedule.
Monitor for toxicity – Regular monitoring is essential.
Stay informed – New PI3K inhibitors are being developed.
ENGAGEMENT QUESTION
💬 Have you or someone you know been treated with a PI3K inhibitor? What was the experience – and what type of cancer was being treated? Share below!